Imagen de Portada

Performance of plasma p‐tau217 and NfL in an unselected memory clinic setting

Fuente: Wiley Open Access

Guardado en:

Detalles Bibliográficos
Autores principales:	Rebecca Z. Rousset, Thomas Claessen, Argonde C. van Harten, Afina W. Lemstra, Yolande A. L. Pijnenburg, Wiesje M. van der Flier, Anouk den Braber, Andreas Jeromin, Inge M. W. Verberk, Charlotte E. Teunissen
Formato:	Artículo Open Access
Publicado:	Wiley 2024
Materias:	Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
Acceso en línea:	Acceder al recurso
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Response to the letter to the editor “Blood‐based biomarkers for Alzheimer's disease in primary care: A French qualitative study exploring perspectives of general practitioners”
por: Thomas Claessen, et al.
Publicado: (2026)

Impact of COVID‐19 pandemic on mortality rate in memory clinic patients
por: Els D. Bakker, et al.
Publicado: (2024)

Amyloid‐related changes in fluency in patients with subjective cognitive decline
por: Rosanne L. van den Berg, et al.
Publicado: (2025)

General practitioners’ perspectives on blood biomarkers for Alzheimer's disease
por: Thomas Claessen, et al.
Publicado: (2025)

Clinical performance of scalable automated p‐tau 217 multi‐analyte algorithmic blood test with reduced intermediate zone using multiplexed digital immunoassay
por: David H. Wilson, et al.
Publicado: (2025)

Survey among experts on the future role of tau‐PET in clinical practice and trials
por: Marie R. Vermeiren, et al.
Publicado: (2024)

Long‐term cost‐effectiveness of a more accurate diagnostic work‐up for dementia
por: Pieter J. van der Veere, et al.
Publicado: (2025)

Use of a multimarker blood test in the heterogenous memory clinic setting: an updated and simplified interpretation tool
por: Inge M.W. Verberk, et al.
Publicado: (2025)

The relationship between cognitive screeners and everyday functioning in amyloid‐positive participants from the Amsterdam Dementia Cohort
por: Angela van der Putten‐Toorenburg, et al.
Publicado: (2026)

“Real‐world” eligibility for anti‐amyloid treatment in a tertiary memory clinic setting
por: Sinthujah Vigneswaran, et al.
Publicado: (2025)

Cardiovascular rate pressure product is associated with NfL in older adults at risk for AD
por: Chinenye C. Odo, et al.
Publicado: (2025)

‘Real‐world’ eligibility for anti‐amyloid treatment in a tertiary memory clinic setting
por: Sinthujah Vigneswaran, et al.
Publicado: (2025)

Discovery of cerebrospinal fluid biomarkers for different dementias using mass spectrometry‐based proteomics
por: Marijke E. Stokkel, et al.
Publicado: (2026)

Serum NfL , GFAP , and p‐tau217 in adults with drug‐resistant epilepsy and intellectual disabilities: Signs of ongoing neural injury
por: Hadassa Kwetsie, et al.
Publicado: (2026)

Plasma p‐tau217 for Alzheimer's disease diagnosis: a memory clinic implementation approach
por: Giorgia Brodini, et al.
Publicado: (2026)

Prevalence of corpus callosum pathology in an unselected population. Should assessment of the corpus callosum be included in the routine 20 weeks scan?
por: Mª Angeles Rodríguez, et al.
Publicado: (2024)

A Prospective Evaluation of Real‐World Experience with an Alzheimer's Blood‐Based Biomarker Panel in Memory Clinics: The CANTATE Project
por: Sinthujah Vigneswaran, et al.
Publicado: (2025)

Autonomic dysfunction and hypothalamic atrophy in frontotemporal dementia and primary psychiatric disorders
por: Yannick S. S. Timar, et al.
Publicado: (2026)

Test performance and clinical utility of expanded non‐invasive prenatal test: Experience on 71,883 unselected routine cases from one single center
por: Monica Faieta, et al.
Publicado: (2024)

Diagnostic utility of plasma p‐tau217 differs by Alzheimer's disease tau‐based subtypes
por: Seyed Hani Hojjati, et al.
Publicado: (2025)

How can Alzheimer's disease blood‐based biomarkers reach clinical practice?
por: Robert Perneczky, et al.
Publicado: (2025)

Preclinical dementia rating scores are associated with plasma phosphorylated tau‐217
por: Qi Huang, et al.
Publicado: (2025)

Plasma p‐tau217 and APOE genotype: Prodromal Alzheimer's disease staging
por: Ann M. Stowe, et al.
Publicado: (2026)

Cross‐sectional study of plasma phosphorylated tau 217 in persons without dementia
por: Toni T. Saari, et al.
Publicado: (2025)

CSF biomarkers trajectories across the AD spectrum reveal the temporal dynamics of amyloid and tau
por: Diederick Martijn de Leeuw, et al.
Publicado: (2024)

Comparison of three plasma p‐tau217 assays to detect PET‐confirmed Alzheimer's pathologies
por: Sayo Matsuura, et al.
Publicado: (2026)

Associations of plasma phosphorylated tau217 with cognitive impairment and brain microstructural alterations in Alzheimer's disease
por: Miguel Ángel Rivas‐Fernández, et al.
Publicado: (2026)

Clinical validation of the Lilly SP‐X P‐tau217 assay: Performance in underrepresented cohorts
por: Michael E. Hodsdon, et al.
Publicado: (2025)

Clinical and neuropathological associations of plasma Aβ42/Aβ40, p‐tau217 and neurofilament light in sporadic frontotemporal dementia spectrum disorders
por: Binita Rajbanshi, et al.
Publicado: (2025)

Pregnancy Complications in Fetal Congenital Heart Disease: A Result of Common Early Developmental Pathways Rather Than Fetal Hemodynamics
por: Maartje C. Snoep, et al.
Publicado: (2025)

Clinical decision points for two plasma p‐tau217 laboratory developed tests in neuropathology confirmed samples
por: Anna E. Mammel, et al.
Publicado: (2025)

Clinical performance of the fully automated Lumipulse plasma p‐tau217 assay in mild cognitive impairment and mild dementia
por: Adam H. Dyer, et al.
Publicado: (2025)

Plasma p‐tau217 and cognitive impairment: Evaluating biomarker equity across racial/ethnic groups in HABS‐HD
por: Cellas A. Hayes, et al.
Publicado: (2026)

P‐tau217 testing impact on intended management of patients presenting with cognitive impairment: A randomized clinical utility study
por: Samantha C. Burnham, et al.
Publicado: (2025)

Sotalol Dose Optimization for Fetal Tachycardia: A Pregnancy Physiologically Based Pharmacokinetic Model Study
por: Hedwig van Hove, et al.
Publicado: (2026)

Phenotype‐to‐Genotype Description of Prenatal Suspected and Postnatal Discovered Upper Limb Anomalies: A Retrospective Cohort Study
por: Arda Arduç, et al.
Publicado: (2024)

Prenatal Detection of Fetal Abdominal Cysts: Can We Reassure Future Parents?
por: H. Heinrich, et al.
Publicado: (2026)

ARTS is associated with NfL but not with p ‐tau217
por: Gulam Mahfuz Chowdhury, et al.
Publicado: (2025)

Eliminating first trimester combined testing: Consequences for early detection of significant fetal anomalies
por: M. A. Lugthart, et al.
Publicado: (2024)

Elevated tau in the piriform cortex in Alzheimer's but not Parkinson's disease using PET‐MR
por: Hossein Moein Taghavi, et al.
Publicado: (2024)